Authors:
Rocchi, S
Picard, F
Vamecq, J
Gelman, L
Potier, N
Zeyer, D
Dubuquoy, L
Bac, P
Champy, MF
Plunket, KD
Leesnitzer, LM
Blanchard, SG
Desreumaux, P
Moras, D
Renaud, JP
Auwerx, J
Citation: S. Rocchi et al., A unique PPAR gamma ligand with potent insulin-sensitizing yet weak adipogenic activity, MOL CELL, 8(4), 2001, pp. 737-747
Citation: Kg. Liu et al., Synthesis and biological activity of L-tyrosine-based PPAR gamma agonists with reduced molecular weight, BIOORG MED, 11(24), 2001, pp. 3111-3113
Authors:
Liu, KG
Lambert, MH
Leesnitzer, LM
Oliver, W
Ott, RJ
Plunket, KD
Stuart, LW
Brown, PJ
Willson, TM
Sternbach, DD
Citation: Kg. Liu et al., Identification of a series of PPAR-gamma/delta dual agonists via solid-phase parallel synthesis, BIOORG MED, 11(22), 2001, pp. 2959-2962
Citation: Kg. Liu et al., Identification of a series of oxadiazole-substituted alpha-isopropoxy phenylpropanoic acids with activity on PPAR alpha, PPAR-gamma, and PPAR delta, BIOORG MED, 11(17), 2001, pp. 2385-2388
Authors:
Oliver, WR
Shenk, JL
Snaith, MR
Russell, CS
Plunket, KD
Bodkin, NL
Lewis, MC
Winegar, DA
Sznaidman, ML
Lambert, MH
Xu, HE
Sternbach, DD
Kliewer, SA
Hansen, BC
Willson, TM
Citation: Wr. Oliver et al., A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport, P NAS US, 98(9), 2001, pp. 5306-5311
Authors:
Xu, HE
Lambert, MH
Montana, VG
Plunket, KD
Moore, LB
Collins, JB
Oplinger, JA
Kliewer, SA
Gampe, RT
McKee, DD
Moore, JT
Willson, TM
Citation: He. Xu et al., Structural determinants of ligand binding selectivity between the peroxisome proliferator-activated receptors, P NAS US, 98(24), 2001, pp. 13919-13924
Citation: Yp. Wang et al., A synthetic triterpenoid, 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid (CDDO), is a ligand for the peroxisome proliferator-activated receptor gamma, MOL ENDOCR, 14(10), 2000, pp. 1550-1556
Authors:
Henke, BR
Adkison, KK
Blanchard, SG
Leesnitzer, LM
Mook, RA
Plunket, KD
Ray, JA
Roberson, C
Unwalla, R
Willson, TM
Citation: Br. Henke et al., Synthesis and biological activity of a novel series of indole-derived PPARgamma agonists, BIOORG MED, 9(23), 1999, pp. 3329-3334
Authors:
Brown, PJ
Winegar, DA
Plunket, KD
Moore, LB
Lewis, MC
Wilson, JG
Sundseth, SS
Koble, CS
Wu, ZD
Chapman, JM
Lehmann, JM
Kliewer, SA
Willson, TM
Citation: Pj. Brown et al., A ureido-thioisobutyric acid (GW9578) is a subtype-selective PPAR alpha agonist with potent lipid-lowering activity, J MED CHEM, 42(19), 1999, pp. 3785-3788
Authors:
Brown, KK
Henke, BR
Blanchard, SG
Cobb, JE
Mook, R
Kaldor, I
Kliewer, SA
Lehmann, JM
Lenhard, JM
Harrington, WW
Novak, PJ
Faison, W
Binz, JG
Hashim, MA
Oliver, WO
Brown, HR
Parks, DJ
Plunket, KD
Tong, WQ
Menius, JA
Adkison, K
Noble, SA
Willson, TM
Citation: Kk. Brown et al., A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty rat, DIABETES, 48(7), 1999, pp. 1415-1424
Authors:
Henke, BR
Blanchard, SG
Brackeen, MF
Brown, KK
Cobb, JE
Collins, JL
Harrington, WW
Hashim, MA
Hull-Ryde, EA
Kaldor, I
Kliewer, SA
Lake, DH
Leesnitzer, LM
Lehmann, JM
Lenhard, JM
Orband-Miller, LA
Miller, JF
Mook, RA
Noble, SA
Oliver, W
Parks, DJ
Plunket, KD
Szewczyk, JR
Willson, TM
Citation: Br. Henke et al., N-(2-benzoylphenyl)-L-tyrosine PPAR gamma agonists. 1. Discovery of a novel series of potent antihyperglycemic and antihyperlipidemic agents, J MED CHEM, 41(25), 1998, pp. 5020-5036
Authors:
Cobb, JE
Blanchard, SG
Boswell, EG
Brown, KK
Charifson, PS
Cooper, JP
Collins, JL
Dezube, M
Henke, BR
Hull-Ryde, EA
Lake, DH
Lenhard, JM
Oliver, W
Oplinger, J
Pentti, M
Parks, DJ
Plunket, KD
Tong, WQ
Citation: Je. Cobb et al., N-(2-benzoylphenyl)-L-tyrosine PPAR gamma agonists. 3. Structure-activity relationship and optimization of the N-aryl substituent, J MED CHEM, 41(25), 1998, pp. 5055-5069